Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Clinical Investigation

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12235117PMCID PMC151125
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Affinity-purified human Interleukin I is cytotoxic to isolated islets of Langerhans

  2006cited by this paper
• beta-cell apoptosis and defense mechanisms: lessons from type 1 diabetes.

  2001cited by this paper
• Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis.

  2001cited by this paper
• Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-kappaB and C/EBP.

  2001cited by this paper
• Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets.

  2001cited by this paper
• Pancreatic beta-cell damage mediated by beta-cell production of interleukin-1. A novel mechanism for virus-induced diabetes.

  2001cited by this paper
• Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1β-exposed human and rat islet cells

  2001cited by this paper
• Apoptosis-inducing Membrane Vesicles

  2001cited by this paper
• Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function.

  2001cited by this paper
• High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program.

  2001cited by this paper
• Glucose toxicity.

  2001cited by this paper
• The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes

  2001cited by this paper
• beta-Cell death during progression to diabetes.

  2001cited by this paper
• Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-).

  2000cited by this paper
• Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes?

  2000cited by this paper
• Prevention of beta cell dysfunction and apoptosis activation in human islets by adenoviral gene transfer of the insulin-like growth factor I

  2000cited by this paper
• Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor.

  2000cited by this paper
• Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine beta-cell damage.

  2000cited by this paper
• Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes.

  2000cited by this paper
• Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantations.

  2000cited by this paper
• Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes.

  1999cited by this paper
• How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.

  1999cited by this paper
• Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose.

  1999cited by this paper
• Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro.

  1999cited by this paper
• Glucose and tolbutamide induce apoptosis in pancreatic beta-cells. A process dependent on intracellular Ca2+ concentration.

  1998cited by this paper
• Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation.

  1998cited by this paper
• Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes.

  1998cited by this paper
• Improved Human Islet Isolation Using a New Enzyme Blend, Liberase

  1997cited by this paper
• Processing of engulfed apoptotic bodies yields T cell epitopes.

  1997cited by this paper
• Nitric Oxide Primes Pancreatic β Cells for Fas-mediated Destruction in Insulin-dependent Diabetes Mellitus

  1997cited by this paper
• The role of interleukin-1 in the pathogenesis of IDDM

  1996cited by this paper
• Mouse islet cell lysis mediated by interleukin-1-induced Fas

  1996cited by this paper
• Cytokines activate the nuclear factor kappa B (NF-kappa B) and induce nitric oxide production in human pancreatic islets.

  1996cited by this paper
• Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism.

  1995cited by this paper
• The intraislet macrophage and type I diabetes.

  1994cited by this paper
• Differentiating Glucose Toxicity From Glucose Desensitization: A New Message From the Insulin Gene

  1994cited by this paper
• Hyperproinsulinemia and insulin deficiency in the diabetic Psammomys obesus.

  1994cited by this paper
• Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans.

  1993cited by this paper
• Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes.

  1993cited by this paper
• Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function.

  1992cited by this paper
• Antibodies to Glutamic Acid Decarboxylase Discriminate Major Types of Diabetes Mellitus

  1992cited by this paper
• Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations.

  1992cited by this paper
• Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

  1992cited by this paper
• Monolayer culture of adult rat pancreatic islets on extracellular matrix: modulation of B-cell function by chronic exposure to high glucose.

  1991cited by this paper
• Interleukin-1 beta-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1 beta-induced inhibition of insulin secretion.

  1991cited by this paper
• Activation of intraislet lymphoid cells causes destruction of islet cells.

  1991cited by this paper
• Glucose Toxicity

  1990cited by this paper
• Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture.

  1990cited by this paper
• Type II Diabetes, Glucose “Non-Sense,” and Islet Desensitization

  1989cited by this paper
• Automated Method for Isolation of Human Pancreatic Islets

  1988cited by this paper
• Interleukin 1 dose-dependently affects the biosynthesis of (pro)insulin in isolated rat islets of Langerhans

  1987cited by this paper
• Low concentrations of interleukin-1 stimulate and high concentrations inhibit insulin release from isolated rat islets of Langerhans.

  1986cited by this paper
• Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions.

  1986cited by this paper
• Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans.

  1986cited by this paper
• Cytokines Cause Functional and Structural Damage to Isolated Islets of Langerhans

  1985cited by this paper
• Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes

  1985cited by this paper
• Glucagon physiology and pathophysiology in the light of new advances

  1985cited by this paper

• Immunometabolism in obesity: Understanding the beneficial and detrimental roles of inflammation

  2026cites this paper
• Role of Interleukins in Type 1 and Type 2 Diabetes

  2025cites this paper
• Probiotic reduces vaginal HPV abundance, improves immunity and quality of life in HPV-positive women: a randomised, placebo-controlled and double-blind study.

  2025cites this paper
• Pro-inflammatory cytokines as regulators of protein tyrosine phosphatases and insulin signaling in murine skeletal muscle cells.

  2025cites this paper
• Oxidative Stress Induced by Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) Dysfunction Aggravates Chronic Inflammation Through the NAD+/SIRT3 Axis and Promotes Renal Injury in Diabetes

  2025cites this paper
• Managing post-bariatric hypoglycemia: a systematic review of pharmacological therapies

  2025cites this paper
• Hydroxytyrosol from Olive Oil Mitigates Endothelial Dysfunction in Diabetic Foot Ulcers via Redox, Inflammatory, and Survival Pathways.

  2025cites this paper
• Interdisciplinary perspectives on diabetes and microcirculatory dysfunction: A global bibliometric analysis

  2025cites this paper
• MCT1‐mediated Lactate Shuttle to Mitochondria Governs Macrophage Polarization and Modulates Glucose Homeostasis by Affecting β Cells

  2025cites this paper
• Association of IL-1β rs16944 polymorphisms and the subsequent level of IL-1β in type 2 diabetes mellitus: Case-control study

  2025cites this paper
• Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial—the CanpHy study

  2025cites this paper
• Discovery and Phase 1 study of a novel monoclonal antibody against human IL-1β for the treatment of IL-1β-mediated diseases.

  2025cites this paper
• The Role and the Regulation of NLRP3 Inflammasome in Irritable Bowel Syndrome: A Narrative Review

  2025cites this paper
• MODY PDX1P33T: a mouse model reveals phenotypic divergence from human disease

  2025cites this paper
• 12-Lipoxygenase inhibition improves glucose homeostasis and obesity-associated inflammation in human gene replacement mice

  2025cites this paper
• IL-1β priming triggers an adaptive stress response that enhances pancreatic β-cell resilience to subsequent cytotoxic inflammatory insult

  2025cites this paper
• Physiological Fatty Acid-Stimulated Insulin Secretion and Redox Signaling Versus Lipotoxicity

  2025cites this paper
• Excess Fructose Intake Activates Hyperinsulinemia and Mitogenic MAPK Pathways in Association With Cellular Stress, Inflammation, and Apoptosis in the Pancreas of Rats

  2025cites this paper
• Thioredoxin-Interacting Protein (TXNIP) in Gestational Diabetes Mellitus

  2025cites this paper
• Eplerenone alleviates diabetic cardiomyopathy by modulating ER stress, oxidative stress, and NLRP3 inflammasome activation

  2025cites this paper
• Elevated inflammation supra-additively promotes the progression from prediabetes to diabetes: a prospective cohort study

  2025cites this paper
• Obesity, diabetes, and inflammation: Pathophysiology and clinical implications.

  2025cites this paper
• Interactions between islet-resident macrophages and β cells in diabetes

  2025cites this paper
• Clonal haematopoiesis of indeterminate potential: an emerging risk factor for type 2 diabetes and related complications

  2025cites this paper
• 12-Lipoxygenase inhibition improves glycemia and obesity-associated inflammation in male human gene replacement mice.

  2025cites this paper
• Chemerin as a Driver of Cardiovascular Diseases: New Perspectives and Future Directions

  2025cites this paper
• Immunomodulatory Effect of Rivaroxaban Nanoparticles Alone and in Combination with Sitagliptin on Diabetic Rat Model

  2025cites this paper
• Probiotic enhanced immunity and mental wellbeing of generally healthy women: a randomised, placebo-controlled and double-blind study.

  2025cites this paper
• Effects of continuous and interval training on inflammatory and vascular adhesion markers in sedentary individuals with type 1 diabetes

  2025cites this paper
• Inflammation in cardiovascular-kidney-metabolic syndrome: key roles and underlying mechanisms–a comprehensive review

  2025cites this paper
• Association Between Systemic Neuroinflammation, Pain Perception and Clinical Status in Fibromyalgia Patients: Cross-Sectional Study

  2024cites this paper
• Gestational Diabetes Mellitus-Induced Inflammation in the Placenta via IL-1β and Toll-like Receptor Pathways

  2024cites this paper
• The general glycan profiling of Dendrobium officinale and their protective effects on MIN6 cells via ERK signaling pathway.

  2024cites this paper
• Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy

  2024cites this paper
• Hydroxychloroquine as an Adjunct Therapy for Diabetes in Pregnancy

  2024cites this paper
• Targeting the NLRP3 inflammasome–IL-1β pathway in type 2 diabetes and obesity

  2024cites this paper
• Exploring the therapeutic potential of Chinese herbs on comorbid type 2 diabetes mellitus and Parkinson's disease: A mechanistic study.

  2024cites this paper
• Increase in the Expression of Glucose Transporter 2 (GLUT2) on the Peripheral Blood Insulin-Producing Cells (PB-IPC) in Type 1 Diabetic Patients after Receiving Stem Cell Educator Therapy

  2024cites this paper
• The Other Side of the Perfect Cup: Coffee-Derived Non-Polyphenols and Their Roles in Mitigating Factors Affecting the Pathogenesis of Type 2 Diabetes

  2024cites this paper
• Implications of the cGAS-STING pathway in diabetes: Risk factors and therapeutic strategies.

  2024cites this paper
• Glycolysis and beyond in glucose metabolism: exploring pulmonary fibrosis at the metabolic crossroads

  2024cites this paper
• TSPO in pancreatic beta cells and its possible involvement in type 2 diabetes.

  2024cites this paper
• The Impact of Prevotella on Neurobiology in Aging: Deciphering Dendritic Cell Activity and Inflammatory Dynamics

  2024cites this paper
• Tipping-point transition from transient to persistent inflammation in pancreatic islets

  2024cites this paper
• Endoplasmic reticulum stress in pancreatic β-cell dysfunction: The potential therapeutic role of dietary flavonoids

  2024cites this paper
• NLRP3 Inflammasome in Autoinflammatory Diseases and Periodontitis Advance in the Management

  2024cites this paper
• RETRACTED ARTICLE: Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes

  2024cites this paper
• Animal Models for Understanding the Mechanisms of Beta Cell Death during Type 2 Diabetes Pathogenesis

  2024cites this paper
• Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis

  2024cites this paper
• Increased glycemic variability results in abnormal differentiation of T cell subpopulation in type 2 diabetes patients.

  2024cites this paper
• Feline Diabetes Is Associated with Deficits in Markers of Insulin Signaling in Peripheral Tissues

  2024cites this paper
• CD36 inhibition corrects lipid-FetuinA mediated insulin secretory defects by preventing intracellular lipid accumulation and inflammation in the pancreatic beta cells.

  2024cites this paper
• Surprising magic of CD24 beyond cancer

  2024cites this paper
• Autophagy and nutrigenomics: a winning team against chronic disease and tumors

  2024cites this paper
• Repression of latent NF-κB enhancers by PDX1 regulates β cell functional heterogeneity.

  2024cites this paper
• Role of fatty acids in the pathogenesis of ß-cell failure and Type-2 diabetes.

  2024cites this paper
• The genetic advantage of healthy centenarians: unraveling the central role of NLRP3 in exceptional healthspan

  2024cites this paper
• IL-1β promotes adipogenesis by directly targeting adipocyte precursors

  2024cites this paper
• Adiposity, immunity, and inflammation: interrelationships in health and disease: A report from 24th annual Harvard nutrition obesity symposium, June 2023.

  2024cites this paper
• Research advances in understanding crosstalk between organs and pancreatic β‐cell dysfunction

  2024cites this paper
• Gut microbiota interventions in type 2 diabetes mellitus: An umbrella review of glycemic indices.

  2024cites this paper
• The Chicken or the Egg Dilemma: Understanding the Interplay between the Immune System and the β Cell in Type 1 Diabetes.

  2024cites this paper
• Gut microbiome signature of metabolically healthy obese individuals according to anthropometric, metabolic and inflammatory parameters

  2024cites this paper
• Aloe juvenna Brandham & S.Carter as α‐Amylase Inhibitor and Hypoglycaemic Agent with Anti‐inflammatory Properties for Diabetes Management

  2024cites this paper
• How do parasitic worms prevent diabetes? An exploration of their influence on macrophage and β-cell crosstalk

  2023influential citation
• Integrated bioinformatics analyses identifying potential biomarkers for type 2 diabetes mellitus and breast cancer: In SIK1-ness and health

  2023cites this paper
• The immunology of heart failure with preserved ejection fraction.

  2023cites this paper
• Physical Activity as a Modern Intervention in the Fight against Obesity-Related Inflammation in Type 2 Diabetes Mellitus and Gestational Diabetes

  2023cites this paper
• Scopoletin protects INS-1 pancreatic β cells from glucotoxicity by reducing oxidative stress and apoptosis.

  2023cites this paper
• Effects of multiple stressors on pancreatic human islets proteome reveal new insights into the pathways involved

  2023cites this paper
• Signaling pathways and intervention for therapy of type 2 diabetes mellitus

  2023cites this paper
• Irisin attenuates pyroptosis in high glucose-induced pancreatic beta cells via the miR-133a-3p/FOXO1 axis.

  2023cites this paper
• Noncanonical Regulation of cAMP-Dependent Insulin Secretion and Its Implications in Type 2 Diabetes.

  2023cites this paper
• Sorting receptor SORCS2 facilitates a protective stress response in pancreatic islets

  2023cites this paper
• Gut Region-Specific Interleukin 1β Induction in Different Myenteric Neuronal Subpopulations of Type 1 Diabetic Rats

  2023cites this paper
• Dual Role of Mitogen-Activated Protein Kinase 8 Interacting Protein-1 in Inflammasome and Pancreatic β-Cell Function

  2023cites this paper
• Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments

  2023cites this paper
• Effects of anti-inflammatory therapies on glycemic control in type 2 diabetes mellitus

  2023cites this paper
• Gentisic acid ameliorates type 2 diabetes induced by Nicotinamide-Streptozotocin in male mice by attenuating pancreatic oxidative stress and inflammation through modulation of Nrf2 and NF-кB pathways.

  2023cites this paper
• Hyptis obtusiflora C. Presl ex Benth Methanolic Extract Exhibits Anti-Inflammatory and Anti-Gastritis Activities via Suppressing AKT/NF-κB Pathway

  2023cites this paper
• The trigger for pancreatic disease: NLRP3 inflammasome

  2023cites this paper
• Mechanism of immune attack in the progression of obesity-related type 2 diabetes

  2023cites this paper
• ATVB IN FOCUS: Dynamic Functionality of Apolipoproteins

  2023cites this paper
• Do Interleukin-1 and Interleukin-6 Antagonists Hold Any Place in the Treatment of Atherosclerotic Cardiovascular Disease and Related Co-Morbidities? An Overview of Available Clinical Evidence

  2023cites this paper
• Irisin suppresses pancreatic β cell pyroptosis in T2DM by inhibiting the NLRP3-GSDMD pathway and activating the Nrf2-TrX/TXNIP signaling axis

  2023cites this paper
• Enteroviral infections are not associated with type 2 diabetes

  2023cites this paper
• Dectin-2 Deficiency Promotes Pro-inflammatory Cytokine Release from Macrophages and Impairs Insulin Secretion.

  2023cites this paper
• Serum Cytokines and Growth Factors in Subjects with Type 1 Diabetes: Associations with Time in Ranges and Glucose Variability

  2023cites this paper
• The alterations of innate immunity and enhanced severity of infections in diabetes mellitus

  2023cites this paper
• Serum mannan-binding lectin-associated serine proteases in early pregnancy for gestational diabetes in Chinese pregnant women

  2023cites this paper
• Gene expression levels of inflammatory mediators in diabetic foot ulcer patients

  2023influential citation
• Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors.

  2023cites this paper
• Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial

  2023cites this paper
• Hypertension in diabetes

  2023cites this paper
• Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications

  2023cites this paper
• Effect of Gestational Diabetes Mellitus on Pancreatic Development in Offspring

  2023cites this paper
• DNA methylation in peripheral blood leukocytes for the association with glucose metabolism and invasive breast cancer

  2023cites this paper
• An Oxylipin-Related Nutrient Pattern and Risk of Type 1 Diabetes in the Diabetes Autoimmunity Study in the Young (DAISY)

  2023cites this paper
• Aging and aging-related diseases: from molecular mechanisms to interventions and treatments

  2022cites this paper
• Citri Reticulatae Pericarpium (Chenpi) Protects against Endothelial Dysfunction and Vascular Inflammation in Diabetic Rats

  2022cites this paper